UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 227

Sortiert nach

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

Leukemia, 2021-11, Vol.35 (11), p.3059-3072

2021

Volltextzugriff (PDF)

Nebulized glycyrrhizin/enoxolone drug modulates IL-17A in COVID-19 patients: a randomized clinical trial

Frontiers in immunology, 2023, Vol.14, p.1282280-1282280

2023

Volltextzugriff (PDF)

Epigenetics of cervical cancer. An overview and therapeutic perspectives

Molecular cancer, 2005-10, Vol.4 (1), p.38-38, Article 38

2005

Volltextzugriff (PDF)

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells

International journal of molecular sciences, 2022-07, Vol.23 (14), p.7715

2022

Volltextzugriff (PDF)

Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

Cancer medicine (Malden, MA), 2019-06, Vol.8 (6), p.2942-2949

2019

Volltextzugriff (PDF)

Impacto de la inteligencia artificial en la Institución Universitaria Americana en la ciudad de Barranquilla

Ad-gnosis, 2024-06, Vol.13 (13), p.1-22

2024

Volltextzugriff (PDF)

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Blood, 2013-05, Vol.121 (22), p.4439-4442

2013

Volltextzugriff (PDF)

Intergluteal Cleft Eccrine Porocarcinoma with Metastasis to Inguinal Region and Lung: Case Report and Review of the Literature

Case reports in oncology, 2020-09, Vol.13 (3), p.1463-1473

2020

Volltextzugriff (PDF)

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Blood, 2018-11, Vol.132 (Supplement 1), p.5197-5197

2018

Volltextzugriff (PDF)

Infectious Complications in Acute Leukemia, Experience in a Public Institution in Mexico

Blood, 2015-12, Vol.126 (23), p.4902-4902

2015

Volltextzugriff (PDF)

Azacitidine Use in a Low Income Country, Effectiveness of a 100mg Fixed Dose

Blood, 2016-12, Vol.128 (22), p.5555-5555

2016

Volltextzugriff (PDF)

Clonal evolution in a patient with CML detected by FISH precedes imatinib treatment failure

BMC cancer, 2007-02, Vol.7 (S1), p.A41-A41, Article A41

2007

Volltextzugriff (PDF)

Serum albumin as a significant prognostic factor for patients with gastric carcinoma

Annals of surgical oncology, 2007-02, Vol.14 (2), p.381-389

2007

Volltextzugriff (PDF)

Functional and Pain Score Improvement with Vertebroplasty in De Novo Multiple Myeloma in a Public Institution in Mexico

Blood, 2016-12, Vol.128 (22), p.3324-3324

2016

Volltextzugriff (PDF)

Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study

Expert opinion on investigational drugs, 2017-04, Vol.26 (4), p.481-487

2017

Volltextzugriff (PDF)

Control and monitoring of medication intake Smiplus

2016 International Conference on Electrical, Electronics, and Optimization Techniques (ICEEOT), 2016, p.4903-4906

2016

Volltextzugriff (PDF)

Evaluation of Residual Minimum Response with Free Serum Light Chains in Patients with Multiple Myeloma Diagnosis

Blood, 2017, Vol.130, p.5372-5372

2017

Volltextzugriff (PDF)

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph +) In IM-Resistant Disease. Report Of 14 New Cases From A Single Center In Mexico

Blood, 2013-11, Vol.122 (21), p.5172-5172

2013

Volltextzugriff (PDF)

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Blood, 2016-12, Vol.128 (22), p.5362-5362

2016

Volltextzugriff (PDF)

Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting

Journal of infection in developing countries, 2022-01, Vol.16 (1), p.63-72

2022

Volltextzugriff (PDF)

Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial

Annals of hematology, 2011-04, Vol.90 (4), p.379-387

2011

Volltextzugriff (PDF)

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Blood, 2012-11, Vol.120 (21), p.1689-1689

2012

Volltextzugriff (PDF)

Competitiveness in the automotive sector in Departmento del Atlantico

Dimensión empresarial, 2017-01, Vol.15 (1)

2017

Volltextzugriff (PDF)

1 – 25 von 227

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(205)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

Nebulized glycyrrhizin/enoxolone drug modulates IL-17A in COVID-19 patients: a randomized clinical trial

Epigenetics of cervical cancer. An overview and therapeutic perspectives

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells

BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival

Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

Impacto de la inteligencia artificial en la Institución Universitaria Americana en la ciudad de Barranquilla

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Intergluteal Cleft Eccrine Porocarcinoma with Metastasis to Inguinal Region and Lung: Case Report and Review of the Literature

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Infectious Complications in Acute Leukemia, Experience in a Public Institution in Mexico

Azacitidine Use in a Low Income Country, Effectiveness of a 100mg Fixed Dose

Clonal evolution in a patient with CML detected by FISH precedes imatinib treatment failure

Serum albumin as a significant prognostic factor for patients with gastric carcinoma

Functional and Pain Score Improvement with Vertebroplasty in De Novo Multiple Myeloma in a Public Institution in Mexico

Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study

Control and monitoring of medication intake Smiplus

Evaluation of Residual Minimum Response with Free Serum Light Chains in Patients with Multiple Myeloma Diagnosis

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph +) In IM-Resistant Disease. Report Of 14 New Cases From A Single Center In Mexico

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Report of 5 Cases of Extramedullary Myeloma with Central Nervous System Involvement Treated with a Combination of Carfilzomib/Thalidomide/Dexamethasone As a First Line Treatment at a Single Institution in Mexico

Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting

Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Competitiveness in the automotive sector in Departmento del Atlantico

Suchergebnisse filtern